{"nct_id":"NCT00870740","title":"Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2016-07","start_date":"2009-02","start_date_type":null,"primary_completion_date":"2012-05","primary_completion_date_type":"ACTUAL","completion_date":"2012-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}